MAPA Gmbh - arama sonuçları

Avrupa Birliği - Almanca - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - wachstum - hormone und analoga der hypophyse und des hypothalamus - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Avrupa Birliği - Fransızca - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - croissance - hormones hypophysaires et hypothalamiques et analogues - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Avrupa Birliği - İsveççe - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - tillväxt - hypofysiska och hypotalamiska hormoner och analoger - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Avrupa Birliği - Hollandaca - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - groei - hypofyse en hypothalamische hormonen en analogen - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - growth - pituitary and hypothalamic hormones and analogues - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).